HDR UK and DPUK granted £2m for new motor neurone disease research initiative
The rapidly progressive neurological condition affects around 5,000 people in the UK
Read More
Tag: motor neurone disease
LifeArc and ALS TDI announce partnership to develop new clinical tools for ALS and MND
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
Read More
Study reveals new aptamer targeting tool can detect early signs of motor neurone disease
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Read More
ALS Association partners with myTomorrows to improve clinical trial accessibility
The fatal motor neurone disease currently does not have a cure available to treat patients
Read More
Sano Genetics launches ‘Light the Way’ programme for MND
The free programme will be offered to those who are affected by the condition
Read More
Documentary highlights new targets to potentially treat motor neurone disease
The terminal condition currently affects around 5,000 people in the UK
Read More
Experimental motor neurone disease therapy shows early promise
Phase I/II study results demonstrate proof-of-concept and proof-of-biology of tofersen
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
